Shuttle Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 0.82
| SHPH Stock | USD 0.85 0.02 2.30% |
Shuttle |
Shuttle Pharmaceuticals Target Price Odds to finish over 0.82
The tendency of Shuttle Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0.82 in 90 days |
| 0.85 | 90 days | 0.82 | under 95 |
Based on a normal probability distribution, the odds of Shuttle Pharmaceuticals to stay above $ 0.82 in 90 days from now is under 95 (This Shuttle Pharmaceuticals probability density function shows the probability of Shuttle Stock to fall within a particular range of prices over 90 days) . Probability of Shuttle Pharmaceuticals price to stay between $ 0.82 and its current price of $0.85 at the end of the 90-day period is about 1.06 .
Given the investment horizon of 90 days Shuttle Pharmaceuticals has a beta of -0.32. This usually implies as returns on the benchmark increase, returns on holding Shuttle Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Shuttle Pharmaceuticals is likely to outperform the market. Additionally Shuttle Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Shuttle Pharmaceuticals Price Density |
| Price |
Predictive Modules for Shuttle Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Shuttle Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Shuttle Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Shuttle Pharmaceuticals is not an exception. The market had few large corrections towards the Shuttle Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Shuttle Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Shuttle Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.06 | |
β | Beta against Dow Jones | -0.32 | |
σ | Overall volatility | 0.35 | |
Ir | Information ratio | -0.15 |
Shuttle Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Shuttle Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Shuttle Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Shuttle Pharmaceuticals generated a negative expected return over the last 90 days | |
| Shuttle Pharmaceuticals has high historical volatility and very poor performance | |
| Shuttle Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Shuttle Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Shuttle Pharmaceuticals currently holds 1.09 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Shuttle Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Shuttle Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.59 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Shuttle Pharmaceuticals currently holds about 50.44 K in cash with (5.58 M) of positive cash flow from operations. | |
| Shuttle Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Roughly 28.0% of Shuttle Pharmaceuticals outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for ... |
Shuttle Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Shuttle Stock often depends not only on the future outlook of the current and potential Shuttle Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Shuttle Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 M | |
| Cash And Short Term Investments | 5.5 M |
Shuttle Pharmaceuticals Technical Analysis
Shuttle Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Shuttle Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Shuttle Pharmaceuticals. In general, you should focus on analyzing Shuttle Stock price patterns and their correlations with different microeconomic environments and drivers.
Shuttle Pharmaceuticals Predictive Forecast Models
Shuttle Pharmaceuticals' time-series forecasting models is one of many Shuttle Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Shuttle Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Shuttle Pharmaceuticals
Checking the ongoing alerts about Shuttle Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Shuttle Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Shuttle Pharmaceuticals generated a negative expected return over the last 90 days | |
| Shuttle Pharmaceuticals has high historical volatility and very poor performance | |
| Shuttle Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Shuttle Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Shuttle Pharmaceuticals currently holds 1.09 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Shuttle Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Shuttle Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.59 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Shuttle Pharmaceuticals currently holds about 50.44 K in cash with (5.58 M) of positive cash flow from operations. | |
| Shuttle Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Roughly 28.0% of Shuttle Pharmaceuticals outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for ... |
Check out Shuttle Pharmaceuticals Backtesting, Shuttle Pharmaceuticals Valuation, Shuttle Pharmaceuticals Correlation, Shuttle Pharmaceuticals Hype Analysis, Shuttle Pharmaceuticals Volatility, Shuttle Pharmaceuticals History as well as Shuttle Pharmaceuticals Performance. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.25) | Return On Assets (0.62) | Return On Equity (1.86) |
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.